Services Articles
A scientific hub to keep you informed about our latest research and company updates.
Accelerating Angelman Syndrome Research: InnoSer now offers Angelman Syndrome Mouse Model
InnoSer Partners with Kabuki Syndrome Foundation to Advance Therapeutic Development for Kabuki Syndrome
InnoSer Presents New Data on Tau[P301S] and α-Synuclein Combination Models for Neurodegenerative Research at ADPD 2025
InnoSer Strengthens Neurology Platform with Acquisition of remynd’s CRO Business
Multiplex Cytokine and Immune Cell Profiling in Immuno-Oncology Research
Targeted Gene Therapy Preclinical Testing Approaches in the ADPKD Mouse Model
Gene Therapy Delivery Strategies: Helping You Address Challenges for CNS Diseases
How to Advance your Preclinical Research Using Mouse Data to Establish PK/PD Relationships
MDX Mouse Model Validation Data
Pancreatic Cancer PDX Models
Project Completion Announcement: CARDIOIDS Collaboration with Professor Leon de Windt Advances Arrhythmogenic Cardiomyopathy (ACM) Research
info@innoserlaboratories.com



![InnoSer Presents New Data on Tau[P301S] and α-Synuclein Combination Models for Neurodegenerative Research at ADPD 2025](https://www.innoserlaboratories.com/wp-content/uploads/2025/03/ADPD-2025-InnoSer-Neurodegenerative-Disease-Models-400x250.png)







